Pharma Industry News
A collection of Pharma latest news, analysis and best practices from top business influencers and the world's most trustworthy sources.
Obesity Drug Boom Buoys Ireland's Pharma Production for Export
This article is for subscribers only. A nondescript industrial estate in Ireland's Midlands region is about to become a flashpoint in the race to dominate the weight-loss drug market. Danish pharmaceutical giant Novo Nordisk is planning to boost…
Essential Pharma strengthens rare disease portfolio with acquisition of Ventavis (iloprost trometamol) for adult primary pulmonary hypertension
Ventavis is an established inhaled prostacyclin analogue for the treatment of primary pulmonary hypertension Acquisition reinforces Essential Pharma's mission to serve the needs of rare disease populations and enhances reputation as a trusted…
Madrigal Pharma: What To Expect With Q4 Earnings Coming Thursday (NASDAQ:MDGL)
Madrigal Pharmaceuticals is reiterated as a Strong Buy ahead of Q4 earnings, with a 12-month price target of $665, implying 43% upside. Rezdiffra's rapid commercialization and first-mover advantage in the MASH market underpin robust sales growth…
Next round of growth in pharma, life sciences will be in high value products: CEOs
To further harness global opportunity in pharma and life sciences, Indian industry needs to move up on the value chain to become a capability leader with focus on high-value products, according to industry captains. The journey towards this end has…
Platform models gaining ground in pharma R&D: Report
Rising scientific complexity is pushing companies to redesign R&D (research and development) around platform-based models rather than one-off products, according to a study by EY-Parthenon India. The report – Pharma's New Architecture: Where…
BridgeBio Pharma (NASDAQ:BBIO) Price Target Raised to $100.00
BridgeBio Pharma (NASDAQ:BBIO - Get Free Report) had its target price raised by research analysts at HC Wainwright from $90.00 to $100.00 in a research note issued to investors on Tuesday, Benzinga reports. The brokerage currently has a 'buy'…
Cibc World Market Inc. Invests $1.23 Million in Ascendis Pharma A/S $ASND
Cibc World Market Inc. acquired a new stake in Ascendis Pharma A/S (NASDAQ:ASND - Free Report) during the third quarter, according to its most recent disclosure with the SEC. The institutional investor acquired 6,168 shares of the biotechnology…
Nuvectis Pharma (NVCT) to Release Quarterly Earnings on Tuesday
Nuvectis Pharma (NASDAQ:NVCT - Get Free Report) will likely be releasing its Q4 2025 results before the market opens on Tuesday, February 24th. Analysts expect Nuvectis Pharma to post earnings of ($0.26) per share for the quarter. Investors can…
Illinois Municipal Retirement Fund Sells 22,256 Shares of Royalty Pharma PLC $RPRX
Illinois Municipal Retirement Fund trimmed its holdings in shares of Royalty Pharma PLC (NASDAQ:RPRX - Free Report) by 28.9% during the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The…
Change to the Roche Enlarged Corporate Executive Committee
Basel, 17 February 2026 - Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced the appointment of Mark Dawson, M.D., Ph.D., as the new Head of Roche Pharma Research and Early Development (pRED), effective 1 May 2026. Based in Basel, he will also…
Keen on making Hyderabad lab of the future: Sridhar Babu
IT and Industries Minister D.Sridhar Babu on Tuesday said Telangana government wants to transform Hyderabad into a global hub for innovation-led Life Sciences growth, a ‘laboratory of the future'. Speaking at BioAsia, which opened here on…
Trump tariffs: Irish exports to US soared in 2025
Mandel NGAN / AFP via Getty Images Economics and business editor, BBC News NI The value of Irish goods exports to the United States soared by 52% to almost €112bn (£97bn) in 2025, official figures suggest. The export performance was…
Decoding mutual fund sector allocation trends
Within equity-oriented mutual funds, Banks, IT-Software, Finance, Pharma and Automobiles remained the most preferred sectors. Banks continued as the largest allocation at nearly 22% of equity AUM, also recording the biggest absolute rise of 31% in…
Sensex down 230 pts, Nifty loses 100 pts in early trade as markets open on cautious note amid US-Iran tensions
The share markets in the country opened on a cautious note on Tuesday amid fresh tensions escalating between the United States and Iran, as the two nations began indirect nuclear talks in Geneva. Rising geopolitical uncertainty and its impact on…
GSK: Post-Pivot Buoyancy Set To Continue After Strong 2025 (Upgrade) (NYSE:GSK)
GSK plc is a pharma worthy of a Buy rating, based on past performance and future prospects. In 2025, the company grew revenues by 7% and core EPS by 12%. GSK seems to have successfully pivoted into a 'pure-play' Pharma having ditched its consumer…
Receive a Daily briefing on Pharma Industry News
Get Started